Literature DB >> 10838049

The IF(1) inhibitor protein of the mitochondrial F(1)F(0)-ATPase.

D W Green1, G J Grover.   

Abstract

Recent studies on the IF(1) inhibitor protein of the mitochondrial F(1)F(0)-ATPase from molecular biochemistry to possible pathophysiological roles are reviewed. The apparent mechanism of IF(1) inhibition of F(1)F(0)-ATPase activity and the biophysical conditions that influence IF(1) activity are summarized. The amino acid sequences of human, bovine, rat and murine IF(1) are compared and domains and residues implicated in IF(1) function examined. Defining the minimal inhibitory sequence of IF(1) and the role of conserved histidines and conformational changes using peptides or recombinant IF(1) is reviewed. Luft's disease, a mitochondrial myopathy where IF(1) is absent, is described with respect to IF(1) relevance to mitochondrial bioenergetics and clinical observations. The possible pathophysiological role of IF(1) in conserving ATP under conditions where cells experience oxygen deprivation (tumor growth, myocardial ischemia) is evaluated. Finally, studies attempting to correlate IF(1) activity to ATP conservation in myocardial ischemic preconditioning are compared.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10838049     DOI: 10.1016/s0005-2728(00)00085-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  39 in total

1.  14-3-3 protein is a regulator of the mitochondrial and chloroplast ATP synthase.

Authors:  T D Bunney; H S van Walraven; A H de Boer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 2.  The structural and functional connection between the catalytic and proton translocating sectors of the mitochondrial F1F0-ATP synthase.

Authors:  S Papa; F Zanotti; A Gaballo
Journal:  J Bioenerg Biomembr       Date:  2000-08       Impact factor: 2.945

3.  Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone.

Authors:  S Cumero; F Fogolari; R Domenis; R Zucchi; I Mavelli; S Contessi
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

4.  Inhibition sites in F1-ATPase from bovine heart mitochondria.

Authors:  Jonathan R Gledhill; John E Walker
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

5.  Interconversion between dimers and monomers of endogenous mitochondrial F1-inhibitor protein complexes and the release of the inhibitor protein. Spectroscopic characteristics of the complexes.

Authors:  Lenin Domínguez-Ramírez; Georgina Garza-Ramos; Hugo Najera; Guillermo Mendoza-Hernández; Armando Gómez-Puyou; Marietta Tuena de Gómez-Puyou
Journal:  J Bioenerg Biomembr       Date:  2004-12       Impact factor: 2.945

6.  Reversible self-association of recombinant bovine factor B.

Authors:  Grigory I Belogrudov; Virgil Schirf; Borries Demeler
Journal:  Biochim Biophys Acta       Date:  2006-09-16

Review 7.  Mitochondrial and cell-surface F0F1ATPsynthase in innate and acquired cardioprotection.

Authors:  Giovanna Lippe; Elena Bisetto; Marina Comelli; Stefania Contessi; Francesca Di Pancrazio; Irene Mavelli
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

8.  Mitochondrial bioenergetic profile and responses to metabolic inhibition in human hepatocarcinoma cell lines with distinct differentiation characteristics.

Authors:  Rossana Domenis; Marina Comelli; Elena Bisetto; Irene Mavelli
Journal:  J Bioenerg Biomembr       Date:  2011-09-01       Impact factor: 2.945

9.  Identification of a conserved calmodulin-binding motif in the sequence of F0F1 ATPsynthase inhibitor protein.

Authors:  Stefania Contessi; Francis Haraux; Irene Mavelli; Giovanna Lippe
Journal:  J Bioenerg Biomembr       Date:  2005-10       Impact factor: 2.945

Review 10.  Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion.

Authors:  Giancarlo Solaini; David A Harris
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.